Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for advanced breast cancer patients with brain metastases: Triple-Drug trial launches

NCT ID NCT05800275

First seen Nov 18, 2025 · Last updated May 20, 2026 · Updated 21 times

Summary

This study tests whether a combination of two oral drugs (tucatinib and capecitabine) plus a chemotherapy given directly into the spinal fluid (intrathecal trastuzumab) can help people with HER2-positive breast cancer that has spread to the lining of the brain and spinal cord. About 30 adults with this condition will receive the treatment. The main goal is to see how many are still alive after 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2-POSITIVE METASTATIC BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Antoine Lacassagne

    RECRUITING

    Nice, 06189, France

    Contact

  • Centre François Baclesse

    RECRUITING

    Caen, 14000, France

    Contact

  • Centre Georges-François Leclerc

    RECRUITING

    Dijon, 21000, France

    Contact

  • Centre Henri Becquerel

    RECRUITING

    Rouen, 7600, France

    Contact

  • Centre Jean Perrin

    RECRUITING

    Clermont-Ferrand, 63011, France

    Contact

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69008, France

    Contact

  • Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

    Contact

  • Institut Bergonié

    WITHDRAWN

    Bordeaux, 33000, France

  • Institut Jean Godinot

    RECRUITING

    Reims, 51100, France

    Contact

  • Institut de cancérologie Strasbourg Europe - ICANS

    RECRUITING

    Strasbourg, 67200, France

    Contact

  • Institut régional du Cancer de Montpellier

    RECRUITING

    Montpellier, 34298, France

    Contact

Conditions

Explore the condition pages connected to this study.